Anaxsys Announces An Independent Pilot Swiss Study In Colonoscopy Recommends The Use Of respiR8™ Continuous Respiratory Rate Counter

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SEND, England--(BUSINESS WIRE)--Anaxsys Ltd, the medical device company developing innovative respiratory devices, today announced that an independent Swiss study ‘ Breath monitoring with a new Respiratory Rate Monitoring Device during Colonoscopy : A pilot study’ recommends the use of respiR8™ continuous respiratory rate counter in colonoscopy procedures. respiR8™, which monitors respiratory rates in post-operative, trauma and emergency procedure patients, has already received a CE Mark and is available in hospitals in the U.K. and Europe.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC